Article Details

FDA Grants Priority Review to Pfizer's RSV Vaccine Candidate for Older Adults

Retrieved on: 2022-12-08 15:09:06

Tags for this article:

Click the tags to see associated articles and topics

FDA Grants Priority Review to Pfizer's RSV Vaccine Candidate for Older Adults. View article details on HISWAI: https://www.pharmacytimes.com/view/fda-grants-priority-review-to-pfizer-s-rsv-vaccine-candidate-for-older-adults

Excerpt

The FDA has granted priority review to a Biologics License Application (BLA) for Pfizer's respiratory syncytial virus (RSV) vaccine candidate, ...

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up